I guess in essence its merely confirmation that Paul is doing his job as expected in his position. Some of the posters here of late have mentioned previously that he has not been proactive in his role and it simply would have highlighted something quite to the contrary. But as you know the recent Clinical Waste conference in Oz was not mentioned to the shareholders until after the fact... Indeed if it weren't for your diligent online searchers Munji, perhaps none of us would have been aware of it until after it happened. And that goes for the up coming South African conference in May and the nature and breadth of excitement in regional targets of MDV's wares... Well done M8.
I guess the highlights of the Half Yearly report is a good indication of where the compass needle is pointing for MDV's future.
Between the WHO initiatives, the Dusseldorf expressed distribution interests on the MetaM and the SWipes arm of the company, tie that in with global swings toward cleaner and greener solutions and MDV seems to be sitting on an invariably lucrative asset. I imagine If Sri Lanka comes through on schedule that by the time the South African conference begins in May, MDV could well have made its mark on the global stage of Clinical Waste Solutions and if thats the case then any representation there could be overwhelmed by further international interest. That's the hope anyway. Might we also see some active investment interest from Europe? if that last investor report link gets into the right hands, then we might hope to see some addition buy pressure at some stage.
So Munj did you manage to find a list of companies attending the conference? I'd expect allot of representatives regional to continental Africa to be there.
Anyway... Cheers..
MDV Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
